Park Vale Capital
Park Vale Capital is an asset management firm headquartered in London, with additional offices in New York, Hong Kong, and Shanghai. The firm specializes in developing and managing long-term fiduciary capital through a range of unique investment strategies. Park Vale focuses on special situations, real estate, new technology, and global energy, aiming to provide high-value investment products via direct deal opportunities, tailored investment solutions, and dedicated funds. The firm is committed to achieving positive performance that is low in correlation to traditional assets, thereby enhancing total asset allocation. With a team of experienced professionals, Park Vale Capital leverages its extensive networks and market insights to identify and manage investment opportunities effectively.
Top Stages
3 past transactions
Cullinan Therapeutics
Series A in 2017
Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics intended to end a drug program quickly if the early research suggests it won't work. The company's therapeutics are developed via assets sourced internally through dry lab or externally through business, academic and pharma collaborations, enabling researchers to get a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model.
Dearman
Venture Round in 2016
Dearman Ltd., established in 2011 and headquartered in London, specializes in developing and delivering clean cold and power technologies. The company's core product, the Dearman engine, is a piston engine driven by the expansion of liquid nitrogen or liquid air, producing zero-emission power and cooling. This technology is applied in various sectors, including refrigerated transport systems for cooling cargo in trucks, backup power and cooling for buildings, and assisting the main drive engine in city buses and urban vehicles. Dearman's innovations aim to reduce operating costs, fuel usage, and emissions, while maintaining low capital costs. The company is currently in commercial trials for its transport refrigeration application, with plans for multi-country trials later in 2016.
Causemo
Series A in 2015
Causemo Inc. is a Framingham, Massachusetts-based company that specializes in developing a fundraising and donor segmentation software as a service (SaaS) platform. Established in 2013, Causemo provides a product known as Causemo Insights, which leverages data science to enhance fundraising efforts for nonprofit organizations. By helping organizations understand their donors' preferences, motivations, and preferred giving channels, the platform enables them to raise more funds effectively and efficiently. Causemo operates as a subsidiary of The Pursuant Group, Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.